GI Stromal Tumors

Heikki Joensuu, Mikael Eriksson, Kirsten Sundby Hall, Jörg T. Hartmann, Daniel Pink, Jochen Schütte, Giuliano Ramadori, Peter Hohenberger, Justus Duyster, Salah-Eddin Al-Batran, Marcus Schlemmer, Sebastian Bauer, Eva Wardelmann, Maarit Sarlomo-Rikala, Bengt Nilsson, Harri Sihto, Odd R. Monge, Petri Bono, Raija Kallio, Aki Vehtari, Mika Leinonen, Thor Alvegård, Peter Reichardt, One vs Three Years of Adjuvant Imatinib for Operable Gastrointestinal Stromal Tumor JAMA. ,vol. 307, pp. 1265- 1272 ,(2012) , 10.1001/JAMA.2012.347

Jean—franÇois Emile, Nathalie Théou, Séverine Tabone, Annie Cortez, Philippe Terrier, Marie—thérèse Chaumette, Catherine Julié, Philippe Bertheau, Anne Lavergne—slove, Jean Donadieu, Alain Barrier, Axel Le Cesne, Brigitte Debuire, Antoinette Lemoine, The Gegist, Clinicopathologic, phenotypic, and genotypic characteristics of gastrointestinal mesenchymal tumors Clinical Gastroenterology and Hepatology. ,vol. 2, pp. 597- 605 ,(2004) , 10.1016/S1542-3565(04)00243-5

Thomas Tran, Jessica A. Davila, Hashem B. El-Serag, The epidemiology of malignant gastrointestinal stromal tumors: an analysis of 1,458 cases from 1992 to 2000. The American Journal of Gastroenterology. ,vol. 100, pp. 162- 168 ,(2005) , 10.1111/J.1572-0241.2005.40709.X

Christopher D.M. Fletcher, Heikki Joensuu, George D. Demetri, Margaret von Mehren, Charles D. Blanke, Annick D. Van den Abbeele, Burton Eisenberg, Peter J. Roberts, Michael C. Heinrich, David A. Tuveson, Samuel Singer, Milos Janicek, Jonathan A. Fletcher, Stuart G. Silverman, Sandra L. Silberman, Renaud Capdeville, Beate Kiese, Bin Peng, Sasa Dimitrijevic, Brian J. Druker, Christopher Corless, Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. The New England Journal of Medicine. ,vol. 347, pp. 472- 480 ,(2002) , 10.1056/NEJMOA020461

Heikki Joensuu, Aki Vehtari, Jaakko Riihimäki, Toshirou Nishida, Sonja E Steigen, Peter Brabec, Lukas Plank, Bengt Nilsson, Claudia Cirilli, Chiara Braconi, Andrea Bordoni, Magnus K Magnusson, Zdenek Linke, Jozef Sufliarsky, Massimo Federico, Jon G Jonasson, Angelo Paolo Dei Tos, Piotr Rutkowski, None, Risk of recurrence of gastrointestinal stromal tumour after surgery: an analysis of pooled population-based cohorts Lancet Oncology. ,vol. 13, pp. 265- 274 ,(2012) , 10.1016/S1470-2045(11)70299-6

Charles D. Blanke, George D. Demetri, Margaret von Mehren, Michael C. Heinrich, Burton Eisenberg, Jonathan A. Fletcher, Christopher L. Corless, Christopher D.M. Fletcher, Peter J. Roberts, Daniela Heinz, Elisabeth Wehre, Zariana Nikolova, Heikki Joensuu, Long-Term Results From a Randomized Phase II Trial of Standard- Versus Higher-Dose Imatinib Mesylate for Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing KIT Journal of Clinical Oncology. ,vol. 26, pp. 620- 625 ,(2008) , 10.1200/JCO.2007.13.4403

George D Demetri, Allan T van Oosterom, Christopher R Garrett, Martin E Blackstein, Manisha H Shah, Jaap Verweij, Grant McArthur, Ian R Judson, Michael C Heinrich, Jeffrey A Morgan, Jayesh Desai, Christopher D Fletcher, Suzanne George, Carlo L Bello, Xin Huang, Charles M Baum, Paolo G Casali, Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial The Lancet. ,vol. 368, pp. 1329- 1338 ,(2006) , 10.1016/S0140-6736(06)69446-4

Ronald P. DeMatteo, Jonathan J. Lewis, Denis Leung, Satvinder S. Mudan, James M. Woodruff, Murray F. Brennan, Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Annals of Surgery. ,vol. 231, pp. 51- 58 ,(2000) , 10.1097/00000658-200001000-00008